Causes of Cancer: Infectious Agents Flashcards
(12 cards)
1
Q
attributable fraction
A
proportion of incidents that are likely to be caused by a risk factor
2
Q
attributable fraction for infectious agents
A
- uk less than 5%
- some countries over 40% (southeast africa)
3
Q
risk based on richness of country
A
- less developed regions = at least 25%
- more developed = at least 10%
4
Q
total number of cases a year due to infectious agents
A
2.2 million
5
Q
most common infections causing cancer
A
- H pylori
- HPV
- Hep b/c
- EBV
- schistosoma haematobium
- liver flukes
6
Q
liver flukes and cancer
A
- cause bile duct cancer
- causes chronic inflammation, which causes higher rates of proliferation and DNA damage
- bile duct cancer very common in china, thailand and south korea, less common in uk, europe
- corresponds with levels of liver fluke infections
7
Q
liver fluke infection cause
A
- eating fish that have been infected by the parasite
- can stay in host for many years
8
Q
H. Pylori and cancer
A
- gastric cancer
- 80-90% attributable fraction for some types
- bacterium damages mucous cells, and causes inflammation and immune response
- stomach ulcers also form
- more proliferation, causes more mutations
9
Q
viruses and cancer
A
HPV- cervix (100%), head and neck (50%)
Hep B- liver (80%)
EBV- pharynx (50%), hodgkins disease (30%)
10
Q
HPV and cancer
A
- many strains (200)
- most harmless- LOW RISK
- some associated with cancer- HIGH RISK (16, 18, 31)
- cervix, head and neck, penile, vulva and anus
11
Q
HPV causing cancer
A
- 8000 bp DNA
- viral E6 and E7 encode oncoproteins
- E6 binds to p53, which targets it for degradation
- prevents cell cycle arrest/apoptosis functions of p53
- E7 binds to Rb1, which targets it for degradation
- prevents Rb1 holding of E2F, so E2F free to promote cell cycle progression
12
Q
retroviruses in cancer
A
- HIV- kaposis sarcoma
- HTLV- T cell leukaemia (3% of people infected develop T-cell leukeamia) common in Japan, Caribbean, US, Italy, Africa
- insertion of cDNA is where problems happen (blocking TSGs and promoting oncogenes)